Phosphoric Acid

Phosphoric Acid

SCHEMBL897840

O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.56
SLC34A1 Q06495 1/20 0.50
FDPS P14324 2/20 0.46
BLM P54132 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MMP2 P08253 2/20 0.46
THRB P10828 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TYMS P04818 1/20 0.39
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.33
PGK1 P00558 2/20 0.33
PGK2 P07205 2/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CA4 P22748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL9126 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL8851940 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL140393 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL1332284 1.00
Phosphoric Acid SCHEMBL22 1.00
Phosphoric Acid SCHEMBL8844890 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL3788505 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL5907 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL36090 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL45358 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209432-A1 POLYPEPTIDE TAGGED NUCLEOTIDES AND USE THEREOF IN NUCLEIC ACID SEQUENCING BY NANOPORE DETECTION Roche Sequencing Solutions, Inc. (US) 2024-06-27 US disclosed
CN-112204154-B Enzymatic enrichment of DNA-pore-polymerase complexes 豪夫迈·罗氏有限公司 2024-06-25 CN disclosed
CN-115052882-B Composition for reducing template penetration into nanopores 豪夫迈·罗氏有限公司 2024-05-24 CN disclosed
EP-4303314-A2 POLYPEPTIDE TAGGED NUCLEOTIDES AND USE THEREOF IN NUCLEIC ACID SEQUENCING BY NANOPORE DETECTION F. Hoffmann-La Roche AG (CH) 2024-01-10 EP disclosed
US-11739378-B2 Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection Roche Sequencing Solutions, Inc. (US) 2023-08-29 US disclosed
CN-109863161-B Labeled polynucleotides useful for nucleic acid sequencing 豪夫迈·罗氏有限公司 2022-06-03 CN disclosed
US-20220090189-A1 POLYPEPTIDE TAGGED NUCLEOTIDES AND USE THEREOF IN NUCLEIC ACID SEQUENCING BY NANOPORE DETECTION Roche Sequencing Solutions, Inc. (US) 2022-03-24 US disclosed
CN-108350017-B Polypeptide-labeled nucleotides and their use in nucleic acid sequencing by nanopore detection 豪夫迈·罗氏有限公司 2022-03-15 CN disclosed
US-20210317521-A1 TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION Roche Sequencing Solutions, Inc. (US) 2021-10-14 US disclosed
US-20210292832-A1 TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING Roche Sequencing Solutions, Inc. (US) 2021-09-23 US disclosed
EP-3347366-A1 POLYPEPTIDE TAGGED NUCLEOTIDES AND USE THEREOF IN NUCLEIC ACID SEQUENCING BY NANOPORE DETECTION H. Hoffnabb-La Roche Ag (CH) 2018-07-18 EP disclosed
WO-2018037096-A1 TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION F. HOFFMANN-LA ROCHE AG (CH) 2018-03-01 WO disclosed
US-20180057870-A1 TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION Roche Sequencing Solutions, Inc. 2018-03-01 US disclosed
WO-2017202917-A1 TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING F. HOFFMANN-LA ROCHE AG (CH) 2017-11-30 WO disclosed
US-20170342485-A1 TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING Roche Sequencing Solutions, Inc. (US) 2017-11-30 US disclosed
WO-2017203059-A1 TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING F. HOFFMANN-LA ROCHE AG (CH) 2017-11-30 WO disclosed
WO-2017042038-A1 POLYPEPTIDE TAGGED NUCLEOTIDES AND USE THEREOF IN NUCLEIC ACID SEQUENCING BY NANOPORE DETECTION F. HOFFMANN-LA ROCHE AG (CH) 2017-03-16 WO disclosed
EP-2621273-A2 POLYPHOSPHATE AND PYROPHOSPHATE DERIVATIVE OF SACCHARIDES Normoxys, Inc. (US) 2013-08-07 EP disclosed
WO-2012045009-A2 POLYPHOSPHATE AND PYROPHOSPHATE DERIVATIVE OF SACCHARIDES NORMOXYS, INC. (US) 2012-04-05 WO disclosed
US-20070264667-A1 Method and system for assaying transferase activity GELLIBOLIAN ROBERT 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739378-B2 Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection NPPA, ANPEP, TENT4A CA2 4445/4885SLC34A1 189/4885FDPS 2103/4885
US-20220090189-A1 POLYPEPTIDE TAGGED NUCLEOTIDES AND USE THEREOF IN NUCLEIC ACID SEQUENCING BY NANOPORE DETECTION NPPA, ANPEP, TENT4A CA2 4445/4885SLC34A1 189/4885FDPS 2103/4885
US-20180057870-A1 TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION PHAX, POLRMT, POLN CA2 3094/4885SLC34A1 33/4885FDPS 1753/4885
US-20210292832-A1 TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING NT5C3B, POLN, RNGTT CA2 4082/4885SLC34A1 271/4885FDPS 376/4885
US-20210317521-A1 TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION PHAX, POLRMT, POLN CA2 3094/4885SLC34A1 33/4885FDPS 1753/4885
US-20240209432-A1 POLYPEPTIDE TAGGED NUCLEOTIDES AND USE THEREOF IN NUCLEIC ACID SEQUENCING BY NANOPORE DETECTION NPPA, ANPEP, TENT4A CA2 4445/4885SLC34A1 189/4885FDPS 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.